Analyst who cast doubt on Provenge vaccine settles with SEC
(Reuters) - A former hedge-fund analyst who argued that Dendreon Corp's therapeutic vaccine for prostate cancer may hasten the death of patients has r...
Source: http://feeds.reuters.com/~r/reuters/healthNews/~3/tETkVQ-qmwI/story01.htm
No comments:
Post a Comment